Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

BEIGENE, LTD.

(BGNE)
  Report
Delayed Nasdaq  -  04:00:00 2023-02-01 pm EST
254.28 USD   -0.67%
02/01BeiGene to Present at Upcoming Investor Conferences
BU
01/31Beigene, Ltd. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
01/24Morgan Stanley Adjusts Price Target on BeiGene to $325 From $295, Maintains Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Bio Therapeutic Drugs
02/01BIONTECH : UBS remains Neutral
MD
01/31Insider Sell: Vertex Pharmaceuticals
MT
01/31Insider Sell: Vertex Pharmaceuticals
MT
01/31Goldman Sachs Adjusts Price Target on BioNTech SE to $156 From $177, Maintains Neutral ..
MT
01/31WuXi AppTec Forecasts Surge in 2022 Profit; Hong Kong Shares Down 3%
MT
01/30UBS Adjusts Vertex Pharmaceuticals Price Target to $373 From $342, Maintains Buy Rating
MT
01/30UBS Adjusts Regeneron Pharmaceuticals' Price Target to $863 From $862, Maintains Buy Ra..
MT
01/30BIONTECH : Gets a Buy rating from Berenberg
MD
01/30Cowen Upgrades Regeneron Pharmaceuticals to Outperform From Market Perform, Adjusts Pri..
MT
01/30South Africa Expects Delivery of Pediatric Pfizer/BioNTech COVID Vaccine Soon
MT
01/30Berenberg Bank Adjusts BioNTech SE's Price Target to $300 From $312, Maintains Buy Rati..
MT
01/30Analyst recommendations: Lockheed Martin, Macy's, Nordstrom, Reg..
MS
01/30Wuxi Apptec Co., Ltd. Provides Earnings Guidance for the Year Ended December 31, 2022
CI
01/30Regeneron Pharmaceuticals, Sanofi Says Dupixent Received Expanded Authorization in Euro..
MT
01/30Sanofi, Regeneron Secure First-in-Class Nod for Dupixent to Treat Eosinophilic Esophagi..
MT
01/30Sanofi and Regeneron's Dupixent wins new European Commission approval
RE
01/30Regeneron Pharmaceuticals, Inc. and Sanofi Announce European Commission Expands the Mar..
CI
01/27Insider Sell: Vertex Pharmaceuticals
MT
01/27Insider Sell: Vertex Pharmaceuticals
MT
01/27Pfizer, BioNTech Reportedly in Talks with EU Over Reducing COVID-19 Vaccine Orders
MT
01/27EU Mulls Changes to COVID-19 Vaccine Deal With BioNTech, Pfizer
MT
01/27Sector Update: Health Care Stocks Flat to Lower Premarket Friday
MT
01/27EU Might Buy Fewer Vaccine Doses From Pfizer, BioNTech for Higher Price, Reuters Report..
DJ
01/27Regeneron, Sanofi Say Dupixent Recommended for Expanded Approval in EU to Treat Atopic ..
MT
01/27Sanofi, Regeneron Win EU Panel's Backing for Dupixent to Treat Atopic Dermatitis in Chi..
MT
01/27Sanofi's and Regeneron's Dupixent wins new stage of EU regulatory approval
RE
01/27Sanofi/Regeneron: Dupixent wins new stage of EU regulatory approval
RE
01/26US CDC Continues Inquiry Into Potential Stroke Link from Pfizer, BioNTech Booster Shot
MT
01/26FDA advisers back the same COVID vaccine for initial shots, boosters
RE
01/25Insider Sell: Vertex Pharmaceuticals
MT
01/24Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $286 From $285, Mainta..
MT
01/24Decibel Therapeutics Gets UK Approval for Hearing Loss Clinical Trial in Pediatric Pati..
MT
01/24Morgan Stanley Raises Price Target on BioNTech to $216 From $203, Maintains Equal-Weigh..
MT
01/23BioNTech Finishes Construction of First Plasmid DNA Manufacturing Site in Germany
MT
01/20JPMorgan Upgrades Regeneron Pharmaceuticals to Overweight From Neutral, $850 Price Targ..
MT
01/20Analyst recommendations: AIG Chubb, Netflix, Regeneron...
MS
01/19Insider Sell: Vertex Pharmaceuticals
MT
01/19Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $296 From $293, Maintai..
MT
01/18EU Health Agency Detects No Safety Signals For Pfizer-BioNTech's Updated COVID-19 Shot
MT
01/18Pasithea Therapeutics Signs Manufacturing Agreement for Drug Candidate PAS-004
MT
01/18Canaccord Genuity Initiates Coverage on Vertex Pharmaceuticals With Hold Rating, $311 P..
MT
01/18Dermapharm falls back from six-week high
DP
01/18Davos 2023: Moderna CEO in talks with China to supply COVID vaccines
RE
01/18Analyst recommendations: Adobe, AstraZeneca, Morgan Stanley, Ora..
MS
01/17SVB Securities Upgrades Vertex Pharmaceuticals to Outperform From Market Perform, Adjus..
MT
01/17Trending: Wuxi Biologics Shareholder Plans Block Sale
DJ
01/17Wuxi Biologics Drops After Major Shareholder Plans to Sell 1.3% Stake
DJ
01/16IG BCE wants drug reserve and 'perspective meeting' with Scholz
DP
01/16BIONTECH : Goldman Sachs reiterates its Neutral rating
MD
01/15US Health Regulators To Probe Pfizer-BioNTech COVID-19 Shot's Potential Link To Stroke
MT
01/13U.S. says Pfizer's bivalent COVID shot may be linked to stroke in older adults
RE
01/13RBC Lifts Price Target on Regeneron Pharmaceuticals to $789 From $782, Maintains Sector..
MT
01/11BioNTech Asks German Court To Cancel CureVac's mRNA Vaccine Patent
MT
01/11Vertex Pharmaceuticals Expands Partnership With Arbor to Cover Precision Gene Editing T..
MT
01/11U.S. to announce list of drugs for pricing negotiations Sept. 1
RE
01/11Pharma Stocks Pull European Equities Lower in Wednesday Trading
MT
01/11BIONTECH : JP Morgan reaffirms its Neutral rating
MD
01/10Insider Sell: Regeneron Pharmaceuticals
MT
01/10Transcript : BioNTech SE Presents at 41st Annual J.P. Morgan Healthcare Confe..
CI
01/10Germany's BioNTech buys British AI startup InstaDeep
RE
01/10BioNTech to Acquire InstaDeep in Cash-and-Stock Deal
MT
01/10BioNTech to Acquire AI Specialist InstaDeep for Up To GBP562 Million
MT
01/10InstaDeep Ltd announced that it expects to receive ú562 million in funding from BioNTec..
CI
01/10BioNTech SE agreed to acquire remaining stake in InstaDeep Ltd for approximately ú560 m..
CI
01/09Transcript : Regeneron Pharmaceuticals, Inc. Presents at 41st Annual J.P. Mor..
CI
01/09Transcript : Vertex Pharmaceuticals Incorporated Presents at 41st Annual J.P...
CI
01/09Regeneron Pharmaceuticals Down Over 8%, on Pace for Largest Percent Decrease Since Marc..
DJ
01/09Tranche Update on Regeneron Pharmaceuticals, Inc.'s Equity Buyback Plan announced on No..
CI
01/06Chinese-made mRNA vaccine starts trial production
RE
01/06Pfizer Reportedly Holding Talks With China for Generic COVID-19 Drug Paxlovid
MT
01/062seventy bio Expands Drug Development Collaboration Project With Regeneron
MT
01/062seventy Bio, Regeneron in Amended Collaboration
DJ
01/062seventy bio, Inc. Announces an Amendment to Its Collaboration with Regeneron
CI
01/06December Jobs Data Eyed as Exchange-Traded Funds, Equity Futures Muted Premarket Friday
MT
01/06BioNTech Teams Up With UK Government to Provide Immunotherapies for Cancer Patients
MT
01/062seventy bio, Inc. announced that it has received $19.999996 million in funding from Re..
CI
01/05BioNTech, UK Government Sign Deal for mRNA Cancer Immunotherapies, Infectious Disease V..
MT
01/05BioNTech SE Announces Strategic Partnership with UK Government to Provide Up to 10,000 ..
CI
01/05Insider Sell: Regeneron Pharmaceuticals
MT
01/05Sensei Biotherapeutics Secures Clinical Supply Deal with Regeneron for Trial
MT
01/05China's CanSino: 'positive' interim data on COVID mRNA vaccine booster t..
RE
01/05Sensei Biotherapeutics, Inc. Announces Clinical Supply Agreement with Regeneron
CI
01/04Momentum Picks Q1 2023 : 5 stocks for the winter
MS
01/01Valneva's COVID-19 Booster Shot Shows Only Marginally Higher Neutralizing Antibody Resp..
MT
2022Vertex Pharmaceuticals Incorporated's Equity Buyback announced on June 24, 2021, has ex..
CI
2022Insider Sell: Regeneron Pharmaceuticals
MT
2022Weak Investors Sentiment Weighs on American Depositary Receipts of European Equities
MT
2022China Reopening Prospects Lend Some Support to European Equities But Uncertain Outlook ..
MT
2022BioNTech Partner Allows China-based Individuals to Secure COVID-19 Boosters in Hong Kon..
MT
2022Regeneron Says Libtayo Approved in Japan for Cervical Cancer
MT
2022Japan Grants Marketing, Manufacturing Authorization for Regeneron Pharmaceuticals' Libt..
MT
2022Regeneron Pharmaceuticals, Inc. Announces Libtayo Receives Approval in Japan for Advanc..
CI
2022BioNTech COVID-19 Booster Vaccine Gets Hong Kong's Approval
MT
2022German Stocks Recover Midday Ahead of Holiday Weekend
MT
2022BioNTech starts human trial to test malaria vaccine
RE
2022BioNTech Begins Phase 1 Trial for Malaria Vaccine Candidate
MT
2022BioNTech Kicks Off Early-Stage Clinical Trial for Malaria Vaccine Candidate
MT
2022BioNTech SE Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165
CI
2022BioNTech's COVID booster vaccine approved in Hong Kong for individuals from age 12
RE
2022BioNTech, Fosun Win Regulatory Nod In Hong Kong For COVID-19 Vaccine For Individuals At..
MT
Upcoming event on BEIGENE, LTD.